Nutriband Advances Fentanyl Patch Development with FDA Meeting as CEO Pursues Presidential Nomination
Nutriband Inc. progresses its abuse-deterrent fentanyl patch AVERSA™ through FDA regulatory pathways while maintaining leadership continuity during CEO Gareth Sheridan's temporary departure for Irish presidential candidacy.
